{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T07:13:55Z","timestamp":1773472435988,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.jpba.2018.05.009","type":"journal-article","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T12:17:28Z","timestamp":1526127448000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Degradation study of irbesartan: Isolation and structural elucidation of novel degradants"],"prefix":"10.1016","volume":"157","author":[{"given":"V.V.S.R.N. Anji Karun","family":"Mutha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh","family":"Guduru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muralidharan","family":"Kaliyaperumal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chidananda Swamy","family":"Rumalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivasa Rao","family":"Maddi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raghu Babu","family":"Korupolu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susheela Bai","family":"Gajbhiye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2018.05.009_bib0005","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1527-3466.1998.tb00354.x","article-title":"A review of the new angiotensin II\u2013receptor antagonist irbesartan","volume":"16","author":"Powell","year":"1998","journal-title":"Cardiovasc. Drug Rev."},{"key":"10.1016\/j.jpba.2018.05.009_bib0010","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0149-2918(04)90022-7","article-title":"The KARTAN study: a postmarketing assessment of Irbesartan in patients with hypertension","volume":"26","author":"Morales-Olivas","year":"2004","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2018.05.009_bib0015","series-title":"International Conference on Harmonisation","article-title":"Stability testing of new drug substances and products Q1A(R2)","author":"ICH","year":"2003"},{"key":"10.1016\/j.jpba.2018.05.009_bib0020","series-title":"Draft Stability Testing of Active Pharmaceutical Ingredients and Pharmaceutical Products","author":"WHO","year":"2007"},{"key":"10.1016\/j.jpba.2018.05.009_bib0025","series-title":"Committee for Proprietary Medicinal Products","article-title":"Note for guidance on stability testing: stability testing of existing active substances and related finished products","author":"CPMP","year":"2002"},{"key":"10.1016\/j.jpba.2018.05.009_bib0030","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0731-7085(02)00047-X","article-title":"Development of validated stability-indicating assay methods\u2014critical review","volume":"28","author":"Bakshi","year":"2002","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.05.009_bib0035","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/10837450802244918","article-title":"Identification and control of a degradation product in avapro\u2122 film-coated tablet: low dose formulation","volume":"13","author":"Wang","year":"2008","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jpba.2018.05.009_bib0040","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/2231-4040.126985","article-title":"A validated stability-indicating liquid chromatographic method for determination of process related impurities and degradation behavior of Irbesartan in solid oral dosage","volume":"5","author":"Goswami","year":"2014","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.jpba.2018.05.009_bib0045","first-page":"920","article-title":"Kinetics of decomposition of irbesartan in aqueous solutions determined by high performance liquid chromatography","volume":"59","author":"Mbah","year":"2004","journal-title":"Pharmazie"},{"key":"10.1016\/j.jpba.2018.05.009_bib0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/10826076.2014.903851","article-title":"Stability indicating RP-HPLC studies for the estimation of irbesartan and amlodipine besylate in pharmaceutical formulations and identification and characterization of degradants using LC\u2013MS","volume":"38","author":"Bodapati","year":"2015","journal-title":"J. Liq. Chromatogr. Relat. Technol."},{"key":"10.1016\/j.jpba.2018.05.009_bib0055","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1556\/AChrom.22.2010.2.3","article-title":"The ICH guidance in practice: stress degradation studies on irbesartan and development of a validated stability-indicating UPLC assay","volume":"22","author":"Sahu","year":"2010","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jpba.2018.05.009_bib0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jpba.2009.11.008","article-title":"Identification and characterization of degradation products of irbesartan using LC\u2013MS\/TOF, MSn, on-line H\/D exchange and LC-NMR","volume":"51","author":"Shah","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.05.009_bib0065","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jpba.2006.04.030","article-title":"Photosensitized degradation of losartan potassium in an extemporaneous suspension formulation","volume":"542","author":"Seburg","year":"2006","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2018.05.009_bib0070","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1039\/a708038g","article-title":"NMR study of desmotropy in Irbesartan, a tetrazole-containing pharmaceutical compound","volume":"2","author":"Bauer","year":"1998","journal-title":"J. Chem. Soc. Perkin Trans."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518304655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708518304655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T12:03:27Z","timestamp":1535112207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708518304655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":14,"alternative-id":["S0731708518304655"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2018.05.009","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Degradation study of irbesartan: Isolation and structural elucidation of novel degradants","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2018.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}